Adverse drug reactions (ADRs) are responsible for drug failure in clinical trials and affect life quality of patients. The identification of ADRs during the early phases of drug development is an important task. Therefore, predicting potential protein targets eliciting ADRs is essential for understanding the pathogenesis of ADRs. In this study, we proposed a computational algorithm,Integrated Network for Protein-ADR relations (INPADR), to infer potential protein-ADR relations based on an integrated network. First, the integrated network was constructed by connecting the protein-protein interaction network and the ADR similarity network using known protein-ADR relations. Then, candidate protein-ADR relations were further prioritized by performing a random walk with restart on this integrated network. Leave-one-out cross validation was used to evaluate the ability of the INPADR. An AUC of 0.8486 was obtained, which was a significant improvement compared to previous methods. We also applied the INPADR to two ADRs to evaluate its accuracy. The results suggested that the INPADR is capable of finding novel protein-ADR relations. This study provides new insight to our understanding of ADRs. The predicted ADR-related proteins will provide a reference for preclinical safety pharmacology studies and facilitate the identification of ADRs during the early phases of drug development.
bining three types of networks, namely the protein-protein interaction network, the ADR similarity network, and the protein-ADR network (see Fig. 1 ). Here, protein-protein interactions (PPI) were obtained from STRING v10 18 . STRING is a comprehensive database containing protein interactions from experimental evidence and comparative genomics prediction methods. It computed a confidence score for each protein interaction based on benchmarking the performance of the predictions against manually curated functional associations in the KEGG database, reflecting the confidence of the predicted interactions. After inputting the above-mentioned set of 3, 198 targetable proteins, we obtained the PPI network including 73,833 interactions between 1,153 proteins. In the PPI network, the vertex set of n proteins is denoted as the set VP = {vp 1 , … , vp n }. Vertex vp i and vp j are linked by an edge, if the confidence score between vp i and vp j from STRING is more than 0. The confidence score was used as the weight of this edge. Next, we used the co-occurrence of drugs to evaluate ADR similarity. For two ADRs i and j, the Jaccard score was calculated as follows:
where D i and D j denote drug sets that cause ADR i and ADR j, respectively. The ADR similarity network was constructed according to the Jaccard score, where the set VA = {va 1 , … , va m } represents the vertex set of m ADRs; vertex va i and va j are linked by an edge, if the Jaccard score for them is greater than 0. The Jaccard score was used as the weight of this edge. Then, human protein-ADR relations were obtained from Kuhn's work and the drug adverse reaction target database (DART, http://xin.cz3.nus.edu.sg/group/drt/dart.asp) 7, 14 . DART is a manually curated database of the known target proteins related to the ADRs that are obtained from the literature. After preprocessing and verifying the names of proteins and ADRs, 503 relations between 245 proteins and 166 ADRs were used as the gold-standard dataset for evaluating the performance of the methods. Here, the identifiers for proteins were Ensemble IDs, and the ADRs were labeled with CUIs. The known 503 protein-ADR relations were represented as a bipartite graph, called the protein-ADR network. In the protein-ADR network, vertex vp i and vertex va j are connected by an edge if the protein i is related to the ADR j. Finally, we constructed the integrated protein and ADR network by connecting the PPI network and the ADR similarity network using the protein-ADR network.
ADR-related protein prediction based on the integrated network. In this work, we used the random walk with restart-based predictor INPADR to infer potential protein-ADR relations (see Fig. 1 ). Random walk with restart (RWR) is a useful method to measure the proximity between two nodes of a network, and has been successfully applied to identify gene-disease relations and drug-target interactions 19, 20 . The RWR method simulates a random walker starting from a source node (or a source set of nodes). At each step, the walker moves to one of the immediate neighbors with equal probability, and restarts from source nodes with a certain probability. After many iterations, the probability of finding the walker at node x converges to the stable probability, which is the proximity score. Therefore, the INPADR includes five steps as follows: (1) network; (2) determining the initial probability; (3) determining the transition matrix; (4) performing RWR on the integrated network; and (5) obtaining the stable probability and ranking the candidate proteins for each ADR.
As mentioned above, the integrated network was generated by combining the PPI network, the ADR similarity network and the protein-ADR network. Let the matrix 
T represent the adjacency matrix of the integrated network, where A n×n , B n×m and C m×m denote the adjacency matrices for the PPI network, the protein-ADR network and the ADR similarity network, respectively. B T is the transpose matrix of B. Second, for an ADR i of interest, ADR va i is considered as the seed node in the ADR similarity network. If protein j is related to ADR i, then vp j is also considered as the seed node in the PPI network 21 . Let u 0 denote the initial probability of the PPI network, where the seed nodes have the equal probabilities with the sum equal to 1 and the probabilities of non-seed nodes are zero. Therefore, the probability for a random walker of starting from each seed node is equal. Let v 0 denote the initial probability of the ADR similarity network, where the probability of node va i is 1 and the probabilities of other nodes are equal to 0. Therefore, the initial probability of the integrated protein and ADR
. The parameter η ∈ (0, 1) is used to measure the importance of the PPI network and the ADR similarity network. The RWR algorithm identified potential proteins related to ADR i by simulating a random walker's transition from its current nodes randomly to neighbors in the integrated protein and ADR network starting at the given seed nodes. From Fig. 1 , we can observe that not all the proteins are linked to ADRs. The ADR similarity network is constructed using the co-occurrence of drugs. Then, the integrated protein and ADR network is constructed by connecting the protein interaction network and the ADR similarity network using known protein-ADR relations retrieved from Kuhn's work and the DART database. Finally, random walk with restart on the integrated network is performed to obtain the stable probability, and candidate ADR-related proteins are ranked according to the stable probability.
When the random walker is in the PPI network, it can jump to the ADR similarity network or stay in the PPI network. If it is at a protein node linked to ADRs, it can jump to one of the linked ADR nodes with the probability λ , or jump to other protein nodes with the probability 1− λ . Otherwise, it only moves in the PPI network. Here, the parameter λ is called the jumping probability of the random walker from the PPI network to the ADR similarity network or vice versa.
Third, the transition matrix needs to be defined to perform the random walk.
denote the transition matrix of the integrated protein and ADR network, where M PP and M AA are intra-subnetwork transition matrices showing the probability from one protein (ADR) to other protein (ADR) in the random walk, respectively; M PA and M AP are inter-subnetwork transition matrices from the PPI (ADR similarity) network to ADR similarity (the PPI) network, respectively. The transition matrix M is defined as follows:
In the PPI network, the transition probability from vertex vp i to vp j is defined as
In the ADR similarity network, the transition probability from vertex va i to va j is defined as
The transition probability from vp i in the PPI network to va j in the ADR similarity network is defined as
The transition probability from va i in the ADR similarity network to vp j in the PPI network is defined as
Next, a random walk is performed on the integrated protein and ADR network using the following Eq. (6)
Here, p t is a vector in which the i-th element is the probability of finding the random walker at node i at step t. The parameter ∈ r (0, 1) is the restart probability of the random walker at the seed nodes at each step. Finally, the stable probability
is obtained after a number of iteration steps, and proteins are ranked according to ∞ u . Based upon the previous work 19 , let the parameters r, λ and η equal to 0.7, 0.5 and 0.5 in our INPADR method, respectively.
Results
The basic properties of the protein-ADR network. In this study, we first focused on the collection of known protein-ADR relations. We obtained 503 relations between 245 proteins and 166 ADRs (see Methods for details). The protein-ADR network was then constructed, which is shown in Fig. 2a . To view the global properties of the protein-ADR network, we performed network topology analysis (see Table 1 ). We further calculated the degree of ADR (protein) nodes, which is the number of proteins (ADRs) associated with the investigated ADR (protein). Each ADR interacted on average with 3 proteins, and each protein interacted on average with 2 ADRs. This result suggested that the dysfunction of multiple proteins contributed to the pathogenesis of ADRs. The degree distribution of the ADR and protein nodes both followed the power law distribution approximately with slopes of − 2.059 and − 1.508 and R 2 = 0.9954 and 0.9824, respectively (see Fig. 2b ,c).
Evaluating ADR-related protein prediction using leave-one-out cross validation. The goal of our study is the prediction of novel protein-ADR relations based on an integrated network (see Methods for details).
To evaluate the performance ability of the INPADR, leave-one-out cross validation (LOOCV) was applied to the 503 known protein-ADR relations. The algorithm cannot prioritize all protein-ADR relations for all the ADRs at the same time. Namely, it can only prioritize candidate proteins for an ADR. Hence, each known protein-ADR relation was removed from the integrated network and was taken as the test dataset in each cross-validation run. The investigated ADR and the remaining proteins related to this ADR were used as seed nodes. For the investigated ADR, all the proteins without known relations with this ADR were regarded as the candidate proteins. When one known protein-ADR relation was taken as a test dataset, we measured how well this test protein ranked relative to the candidate proteins of this ADR. If the ranking of the test protein exceeded a given threshold, then this protein-ADR relation was considered to be successfully predicted by the INPADR. When LOOCV was performed, the sensitivity and specificity for each threshold were calculated. The sensitivity indicates the percentage of the test proteins whose rank is higher than a given threshold, namely the ratio of successfully predicted protein-ADR relations to the total known protein-ADR relations. The specificity indicates the percentage of proteins that are below the threshold. The receiver operating characteristic (ROC) curve plots the sensitivity versus 1-specificity at different thresholds. Then, the area under the ROC curve (AUC) was calculated, which was used as a measure to evaluate the algorithm performance.
Here, we compared our INPADR with the enrichment analysis method based on a hypergeometric test using the integrated protein and ADR network. Enrichment analysis based on a hypergeometric test or Fisher's exact test is a typical method for measuring the significance of the associations between two variables 7, [22] [23] [24] . Kuhn et al. used Fisher's exact test to identify associations between ADRs and proteins by integrating drug-ADR relations and drug-target interactions 7 . Jiang et al. used the hypergeometric distribution to prioritize the entire microRNAome for diseases based on a heterogeneous disease and miRNA network 22 . After performing LOOCV, the INPADR yielded an AUC of 0.8486, while the hypergeometric distribution method only produced an AUC of 0.7437 (Fig. 3a) . This result suggested the INPADR can recover known, experimentally verified protein-ADR relations, and has the power to predict potential protein-ADR relations.
Properties

Values Properties Values
Parameter effect of the INPADR. In the INPADR, there were three parameters: restart probability r, jumping probability λ , and η which controls the impact of two types of seed nodes. It has been shown that the restart probability has little effect on the predictive result [19] [20] [21] . Therefore, we chose a restart probability of 0.7 according to a previous study 19 . The jumping probability λ is responsible for the reinforcement between the PPI network and the ADR similarity network. If λ = 0, the random walker will move in only one type of subnetwork. If λ = 1, the random walker will move only in the protein-ADR network. Namely, he will not reach nodes only in the PPI network or the ADR similarity network. If λ is larger, there is greater mutual dependence of ranking between proteins and ADRs. To investigate the effect of the parameter λ , we set various values of λ ranging from 0.1 to 0.9. The performance of the INPADR was measured using the AUC in the process of LOOCV. The result is shown in Fig. 4 . The performance was improved with an increase of the λ value. When the λ value ranged from 0.5 to 0.9, the AUC values were distributed from 0.85 to 0.89. The performance was comparatively poor for λ values < 0.5, but was superior to the hypergeometric distribution method. It suggested that the INPADR could successfully control the reinforcement between the PPI network and the ADR similarity network.
The parameter η regulates the impact of two types of seed nodes, namely, the protein node and ADR node. If η = 0.5, then the two subnetworks hold the same importance. If η is greater than 0.5, the random walker tends to return to the seed ADRs. The effect of the parameter value on cross-validation results according to the AUC is shown in Fig. 4 . The performance of the INPADR slightly improved when η was set above 0.5, suggesting that the ADR similarity network has an important function for prioritizing the ADR-related proteins.
Comparison with similar method. To further emphasize the importance of the ADR similarity network for the prediction of protein-ADR relations, we compared the INPADR with the RWR (Random Walk with Restart) on only the PPI network 21 . The RWR method is an iterative walker's transition from the current node to its neighboring nodes starting at given seed nodes. Therefore, in the process of LOOCV, the RWR needs at least two proteins for an ADR due to performing a random walk only on the PPI network. Hence, in this comparative analysis, only ADRs related with at least two proteins were considered. We obtained 398 protein-ADR relations between 218 proteins and 61 ADRs as gold-standard data. We then performed LOOCV for each ADR. As shown in Fig. 3b , the ROC curve of the INPADR is above the RWR. The INPADR obtained an AUC value of 0.908, which is higher than the AUC value for the RWR (0.8437). Therefore, the INPADR is superior to the RWR on the protein network alone.
Potential ADR-related protein prediction and case study. After confirming the power of the INPADR to predict novel ADR-related proteins, we applied the INPADR to predict potential proteins for each ADR investigated in this study. The INPADR is a top-k proximity query method which obtained the k proteins with the highest proximity (i.e., the highest stable probability) from a given ADR in the integrated network. In our study, we chose the k of 50 according to previous studies 25, 26 . We publicly released the predictive results for each ADR in Supplementary Table S1, which will provide an experimental reference for biologists. In addition, we performed case studies of two ADRs (hypertension and atherosclerosis) to show the application of the INPADR in predicting the potential ADR-related proteins. For each ADR, all the known ADR-related proteins were used as seed nodes, and candidate proteins (non-seed proteins) were prioritized by the INPADR. The top 50 predictive proteins for two ADRs (see Supplementary Table S1 ) were validated by literature mining and the DisGeNet platform 27 . Hypertension is defined as persistent high systemic arterial blood pressure. There were 18 known proteins related to hypertension. Among the top 50 predictive hypertension-related proteins, 39 proteins had been confirmed to be associated with hypertension by experimental evidence in the literature. Atherosclerosis sometimes occurs in patients treated with ropinirole and naltrexone. There were 7 known proteins related to atherosclerosis. Among the top 50 predictive atherosclerosis-related proteins, 46 proteins had been confirmed to be associated with atherosclerosis by experimental evidence in the literature.
A list of the top 50 potential hypertension-related proteins corresponded to 49 individual genes. According to KEGG gene classification, GPCR receptors and enzymes were the two largest classes of potential hypertension-related proteins (see Fig. 5a ). GPCR receptors (23%) and enzymes (50%) are the most important classes of target proteins in the human genome 28 . The classification of top 50 potential atherosclerosis-related proteins is shown in Supplementary Fig. S1 . Enzymes were also the largest class of potential atherosclerosis-related proteins.
Additionally, the interactions between known ADR-related proteins and the top 50 potential proteins were shown for hypertension and atherosclerosis according to the protein-protein confidence scores (Fig. 5b: hypertension; Supplementary Fig. S1: atherosclerosis) . If the confidence score between two proteins was equal to or larger than 0.7, then the edge linking them was retained. It was found that ADR-related proteins preferred to form some modules, which was consistent with the basic assumption of the INPADR.
Finally, to verify the rationality of the INPADR, we performed functional enrichment analysis for the potential ADR-related proteins using the ClueGo Cytoscape plug-in 29 . Meanwhile, ClueGo constructed a GO biological process similarity network based on shared genes between Go terms (see Fig. 5c : hypertension; Supplementary  Fig. S1 : atherosclerosis). A review of the literature revealed that half of the enriched biological processes were related to hypertension (The biological processes validated in the literature for hypertension and atherosclerosis are listed in Supplementary Table S2 ). For instance, STAT (signal transducers and activators of transcription) proteins are a family of transcription factors that are activated by phosphorylation. Once phosphorylated, STAT protein dimers are transported to the nucleus. STAT family members were involved in diverse biological functions including cell differentiation, proliferation, development, apoptosis, and inflammation 30 . In particular, it was reported that STAT3 played an important role in hypertension 31 . Thus, changes in STAT protein import into the nucleus can lead to the progression of hypertension 32 . The renin-angiotensin system (RAS) is a hormonal cascade regulating blood pressure. Inappropriate activation of the intrarenal RAS was a critical factor to the pathogenesis of hypertension. The plasma renin concentration was used to measure the overall activity of the RAS 33 . Inhibition of renin release into the bloodstream was associated with hypertension. Protein kinase C (PKC) is a family of phospholipid-dependent serine/threonine kinases distributed in different blood vessels. Multiple factors lead to hypertension including changes in neuronal, hormonal, renal and vascular control mechanisms of blood pressure 34 . The activity of PKC can perturb one or more of these physiological control mechanisms, causing persistent increases in blood pressure and hypertension 35 . Hence, dysfunction of protein kinase C deactivation could be associated with hypertension. Therefore, the independent case studies further showed the reliability of our INPADR for identifying the protein-ADR relations.
Discussion
The identification of ADR-related proteins can be used to explain the molecular mechanisms of reported drug-ADR pairs and can be helpful for in vitro ADR assessment at an early phase of drug development. In this study, based on the hypothesis that similar ADRs are caused by proteins that interacted with each other in the PPI network, a computational predictor, INPADR, was developed to identify the potential protein-ADR relations. We first constructed the protein-ADR network based on experimentally verified protein-ADR relations. Network topological analysis revealed that the degree of distribution of the ADR and protein nodes in the protein-ADR network approximately followed the power law distribution. Similar to other biological networks, the protein-ADR network was a scale-free network. We then constructed an integrated network by connecting the PPI network and the ADR similarity network using the protein-ADR network. Then, the candidate proteins for each ADR were ranked by implementing a random walk with restart on the integrated network using the ADR and corresponding known ADR-related proteins as seed nodes. LOOCV was used to evaluate the performance of Scientific RepoRts | 6:36325 | DOI: 10.1038/srep36325 the INPADR. The results revealed that the INPADR was superior to the hypergeometric test and the RWR using only the protein interaction network. The INPADR had the ability to recover the known experimentally verified ADR-related proteins. Furthermore, we performed case studies for two ADRs, and most of the predictive results can be confirmed by database and literature. These case studies further demonstrated that the INPADR has good performance and application value for prioritizing candidate ADR-related proteins. Overall, the good performance of the INPADR was attributed to the fact that the INPADR integrated three different networks into a heterogeneous network, and the experimentally verified ADR-protein relations were used as a gold-standard dataset in cross-validation and seed set to identify potential ADR-related proteins. In addition, the INPADR is based on the topological structure of the integrated network. The scarcity of the experimentally verified protein-ADR relations leads to the incompleteness of the integrated network. Obtaining more known ADR-related proteins will improve the performance of the INPADR. Meanwhile, we plan to integrate more biological data to measure ADR similarity and protein similarity more accurately in future work. 
